Results 31 to 40 of about 8,267,805 (249)
The diagnostic value of a new formula combining age and prostate volume in prostate cancer
Background and objective: This study combined two clinical indicators (age and prostate volume (PV)) to generate age to PV (AVR) ratio, whose diagnostic value for prostate cancer (PCa) was examined based on prostate specific antigen (PSA) in the range
Xiaobo Yang +8 more
doaj +1 more source
Introduction: We sought to determine the distribution of serum prostate specific antigen (PSA) levels in a community-based population in the state of Gujarat in India.
Arvind P Ganpule +3 more
doaj +1 more source
Evaluation of Prostate specific antigen levels and its correlation with histopathological findings
Background: Prostate specific antigen is a tumor marker though is expressed by both normal and neoplastic prostate tissue. The absolute value of Prostate specific antigen is useful for determining the extent of prostate cancer and its treatment. Prostate
Sujata Pudasaini +2 more
doaj +1 more source
Background: Prostate cancer is one of the most common cancers in men, worldwide. Many markers are suggested for prostate cancer with different specificity and sensitivity.
Amal A. Hussein +2 more
doaj
To clarify the recent trends in prostate-specific antigen (PSA) distribution in men in Japan, we analyzed the PSA distributions of men undergoing PSA-based population screening.
Yasuhide Kitagawa +10 more
doaj +1 more source
Supporting Information of all chapters described in the thesis Unravelling the Sugar-Coating of Prostate-Specific Antigen - Method Development and its Application to Prostate Cancer ...
Lageveen-Kammeijer, G.S.M. (Leiden University Medical Center (LUMC)), Researcher +1 more
core +1 more source
Incidental malignancies identified during staging for prostate cancer with 68 Ga prostate-specific membrane antigen HBED-CC positron emission tomography imaging [PDF]
The rapid uptake of 68Ga prostate-specific membrane antigen HBED-CC positron emission tomography (PSMA PET) imaging for prostate cancer staging has led to concerns regarding its specificity, with uptake in both malignant and nonmalignant tissues.
Miles, K +17 more
core +1 more source
Prostate-Specific Antigen in Prostate Cancer
Prostate-specific antigen (PA) has been evaluated clinically as a tumor marker of prostate cancer with the use of enzyme immunoassay (EIA). For serodetection of prostate cancer, PA was assayed in a total of 1,109 sera. From mean ± 3 S.D.
Manabu Kuriyama
doaj +1 more source
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley +1 more source
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source

